在老年患有心房的患者中进行导管切除
Tadashi Yamamoto1,2, Takuya Kishi1,2, Ayako Takamori3
1International University of Health and Welfare Graduate School of Medicine.
International heart journal
|February 2, 2025
概括
对心房动 (AF) 的导管切除在晚年老年患者 (≥75岁) 中是安全有效的,与年轻组相比,其成功率和并发症率相似. 这一过程改善了心脏功能,并降低了天然尿素水平,即使在最老的个体.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 老年医学 老年医学
背景情况:
- 心房动 (AF) 的患病率随着年龄的增长而增加,导管切除是一种常见的治疗方法.
- 老年患者可能会经历较低的成功率和更高的并发症风险与AF切除.
- 与年龄相关的AF切除结果的差异需要进一步调查.
研究的目的:
- 为了比较AF的中年,早期老年 (65-74岁) 和晚年 (≥75岁) 患者的导管切除的特征,成功率和并发症.
- 评估导管切除对心脏功能 (左心室和左心房) 和不同年龄组血B型尿素水平的影响.
主要方法:
- 进行导管切除的AF患者的回顾性比较,分为三个年龄组:中年 (<65岁),早期老年 (65-74岁) 和晚年 (≥75岁).
- 评估程序的成功,复发率和并发症.
- 评估左心室喷射分数,左心房体积指数,左心房空化分数和血B型尿素水平在基线和1年后的消去.
主要成果:
- 在所有年龄组中成功进行了AF切除,复发率没有统计学上显著的差异 (晚年老年:29.7%,早期老年:15.5%,中年:23.1%).
- 在各组中,程序性并发症率相似 (晚年老年:9.5%,早期老年:6.2%,中年:3.3%).
- 晚年老年患者的左心房体积指数较大,并患有更多的并发症 (高血压,心力衰竭,中风). 一年后,在所有组中,包括晚年老年人中,左心室喷射分数,左心房体积指数和左心房空化分数都得到了改善. 在两组老年人中,血B型尿酸水平均下降.
结论:
- 对心房动的导管切除在晚年老年患者 (≥75岁) 中是有效和安全的.
- 该程序显示了心脏结构和功能的显著改善,即使在最老的患者队列中也是如此.
- 并发症率与中年患者的并发症率相似,支持其在老年人中使用.
相关概念视频
Disturbances in Heart Rhythm
884
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
884
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
705
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
705
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
763
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
763


